Cargando…

Emergence of KRAS p.G13D mutation and acquired resistance to cetuximab in colorectal cancer with vulvar metastasis: A case report

RATIONALE: Vulvar metastasis of colorectal cancer (CRC) and acquired resistance to cetuximab is a very rare phenomenon. To our knowledge, few cases have been reported in the English literatures. PATIENT CONCERNS: A 55-year-old woman was diagnosed as adenocarcinoma of the rectum and the primary tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiang, Weiguang, Wu, Qinqin, Ni, Xuefeng, Zhang, Chu, Zhao, Jiemin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922379/ https://www.ncbi.nlm.nih.gov/pubmed/31852167 http://dx.doi.org/10.1097/MD.0000000000018423

Ejemplares similares

Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations
por: Chen, Chih-Chieh, et al.
Publicado: (2013)

Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer: Direct and indirect comparison meta-analysis
por: Kwak, Min Seob, et al.
Publicado: (2017)

KRAS, NRAS, BRAF, PIK3CA, and AKT1 signatures in colorectal cancer patients in south-eastern Romania
por: Brinzan, Costel Stelian, et al.
Publicado: (2022)

Randomized phase II study of cetuximab versus irinotecan and cetuximab in patients with chemo-refractory KRAS codon G13D metastatic colorectal cancer (G13D-study)
por: Nakamura, Masato, et al.
Publicado: (2016)

Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with KRAS p.G13D Mutation
por: Ohishi, Tomokazu, et al.
Publicado: (2020)

Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab
por: Dunn, Emily F., et al.
Publicado: (2010)

Utility of KRAS mutational analysis in the preoperative diagnosis of synchronous pancreatic cancer and intrahepatic cholangiocarcinoma: A case report
por: Eso, Yuji, et al.
Publicado: (2017)

Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III study
por: Hosokawa, Ayumu, et al.
Publicado: (2020)

KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis
por: Xie, Mei, et al.
Publicado: (2017)

Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance
por: Peng, Shaoyong, et al.
Publicado: (2018)

A study of radiomics parameters from dual-energy computed tomography images for lymph node metastasis evaluation in colorectal mucinous adenocarcinoma
por: Liu, Yingying, et al.
Publicado: (2020)

Colorectal cancer with invasive micropapillary components (IMPCs) shows high lymph node metastasis and a poor prognosis: A retrospective clinical study
por: Guo, Zeying, et al.
Publicado: (2020)

The risk of lymph node metastasis makes it unsafe to expand the conventional indications for endoscopic treatment of T1 colorectal cancer: A retrospective study of 428 patients
por: Kim, Bun, et al.
Publicado: (2016)

IRF1-mediated immune cell infiltration is associated with metastasis in colon adenocarcinoma
por: Shao, Yao-jian, et al.
Publicado: (2020)

Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab
por: Zhang, Hangyu, et al.
Publicado: (2020)

Real-World Study of Characteristics and Treatment Outcomes Among Patients with KRAS p.G12C-Mutated or Other KRAS Mutated Metastatic Colorectal Cancer
por: Fakih, Marwan, et al.
Publicado: (2022)

Cetuximab versus bevacizumab maintenance following prior 8-cycle modified FOLFOXIRI plus cetuximab in Asian postmenopausal women with treatment-naive KRAS and BRAF wild-type metastatic colorectal cancer
por: Chen, Baomin, et al.
Publicado: (2020)

The transcriptomic G1–G6 signature of hepatocellular carcinoma in an Asian population: Association of G3 with microvascular invasion
por: Allen, John Carson, et al.
Publicado: (2016)

A practical nomogram included hyperlipidemia for predicting lymph node metastasis in patients with superficial esophageal squamous cell carcinoma
por: Wang, Jing, et al.
Publicado: (2023)

AST to Platelet Ratio Index Predicts Mortality in Hospitalized Patients With Hepatitis B-Related Decompensated Cirrhosis
por: Mao, Weilin, et al.
Publicado: (2016)

Will purposely seeking detect more colorectal polyps than routine performing during colonoscopy?
por: Chu, Yanliu, et al.
Publicado: (2020)

Cyanoacrylate Injection Versus Band Ligation in the Endoscopic Management of Acute Gastric Variceal Bleeding: Meta-Analysis of Randomized, Controlled Studies Based on the PRISMA Statement
por: Qiao, Weiguang, et al.
Publicado: (2015)

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
por: Loupakis, F, et al.
Publicado: (2009)

First case report of retroperitoneal metastasis of fascioliasis after surgery
por: Wang, Jun-Ke, et al.
Publicado: (2017)

Risk factors of missed colorectal lesions after colonoscopy
por: Lee, Jeonghun, et al.
Publicado: (2017)

Association between Helicobacter pylori infection and colorectal polyps
por: Basmaci, Nergis, et al.
Publicado: (2023)

Expression and clinical significance of METTL3 in colorectal cancer
por: Li, Hui, et al.
Publicado: (2023)

Small intestinal obstruction due to the metastasis of intrahepatic cholangiocarcinoma: A case report
por: Akiyama, Shintaro, et al.
Publicado: (2018)

Cetuximab versus bevacizumab following prior FOLFOXIRI and bevacizumab in postmenopausal women with advanced KRAS and BRAF wild-type colorectal cancer: a retrospective study
por: Huang, Chunlong, et al.
Publicado: (2021)

Prognostic Comparison Between Mucinous and Nonmucinous Adenocarcinoma in Colorectal Cancer
por: Park, Jong Seob, et al.
Publicado: (2015)

Optimal timing for the resection of pulmonary metastases in patients with colorectal cancer
por: Yamada, Kazunosuke, et al.
Publicado: (2020)

Colorectal adenocarcinoma with hepatic neuroendocrine carcinoma: A case report
por: Shi, Lingzi, et al.
Publicado: (2023)

Correlation of metastasis characteristics with prognosis in gastric mixed adenoneuroendocrine carcinoma: Two case reports
por: Tang, Qiang, et al.
Publicado: (2017)

Skeletal muscle metastasis from a gastrointestinal stromal tumor: A case report
por: Zhu, Guangsheng, et al.
Publicado: (2021)

Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients
por: Hsu, Hung-Chih, et al.
Publicado: (2016)

The importance of IgG4 screening in patients diagnosed with primary sclerosing cholangitis in the past: A case rediagnosed as IgG4-SC after 10 years
por: Li, Yanni, et al.
Publicado: (2016)

Risk factors for lymph node metastasis of early gastric cancers in patients younger than 40
por: Ji, Tao, et al.
Publicado: (2017)

The epithelioid gastrointestinal stromal tumor with pulmonary metastasis: A rare case report and literature review
por: Xu, Dan, et al.
Publicado: (2020)

COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis
por: Ding, Yun-Long, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hltq7e2k05pb2o31a4g0ejgpvg